Agenzia Italiana del Farmaco
Topiramate: new restrictions to prevent exposure during pregnancy - Topiramate: new restrictions to prevent exposure during pregnancy
Topiramate: new restrictions to prevent exposure during pregnancy
DHPC in agreement with the European Medicines Agency (EMA) and AIFA to inform healthcare professionals of the implementation of a pregnancy prevention programme for topiramate-containing medicinal products.
Published on: 02 November 2023